| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
David R Keefer is Director at DWTX. David R Keefer's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $5K at current prices.
Net of sales, the DWTX filings show accumulation of 5,000 shares.
David R Keefer has 9 Form 4 filings on record from January 2021 to June 2026, all as Director at Dogwood Therapeutics (DWTX), 2021–2026.
The 10 reported transactions were 8 option or other derivative awards, 1 open-market purchase and 1 option exercise.
Counted by filing, the open-market trades come to 1 purchase worth about $29K and no sales.
The only open-market purchase was 5,000 shares of DWTX at an average $5.79 on January 4, 2022, about $29K. Twelve months later DWTX was down 96%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 4, 2022 | DWTX Dogwood Therapeutics, Inc. | Director | Buy | 5,000 | $5.80 | $28,975.00 | New | -17.2% | -95.7% |